Principia Biopharma Inc. Contracts & Agreements
32 Contracts & Agreements
- Business Finance (8 contracts)
- Business Operations (1)
- Human Resources (13)
- Intellectual Property (5)
- Mergers & Acquisitions (1)
- Real Estate (3)
- Uncategorized (1)
- Agreement and Plan of Merger, dated as of August 16, 2020, by and among Principia Biopharma Inc., Sanofi and Kortex Acquisition Corp (Filed With SEC on August 17, 2020)
- Description of Securities (Filed With SEC on March 10, 2020)
- Change in Control and Severance Agreement, by and between Principia Biopharma Inc. and Dolca Thomas, M.D., dated as of April 18, 2019 (Filed With SEC on March 10, 2020)
- Underwriting Agreement related to the Offering, dated October 15, 2019, among Principia Biopharma Inc., BofA Securities, Inc., SVB Leerink LLC, and Wells Fargo Securities, LLC (Filed With SEC on October 18, 2019)
- Offer of Employment, by and between Principia Biopharma Inc. and Dolca Thomas, dated as of August 23, 2018 (Filed With SEC on October 29, 2018)
- Form of Common Stock certificate (Filed With SEC on September 11, 2018)
- License Agreement, by and between the Company and Genzyme Corporation, dated as of November 8, 2017 as amended by that certain First Amendment to License Agreement, dated as of... (Filed With SEC on September 11, 2018)
- Form of Underwriting Agreement (Filed With SEC on September 4, 2018)
- Principia Biopharma Inc. 2018 Equity Incentive Plan, to be in effect on the closing of this offering (Filed With SEC on September 4, 2018)
- Forms of grant notice, stock option agreement and notice of exercise under the Principia Biopharma Inc. 2018 Equity Incentive Plan, to be in effect on the closing of this offering (Filed With SEC on September 4, 2018)
- Form of Change in Control and Severance Agreement to be entered into by Principia Biopharma Inc. and each officer (Filed With SEC on September 4, 2018)
- Principia Biopharma Inc. 2018 Employee Stock Purchase Plan (Filed With SEC on September 4, 2018)
- Form of Indemnification Agreement entered into by and between Principia Biopharma Inc. and each director and executive officer (Filed With SEC on September 4, 2018)
- Offer of Employment, by and between Principia Biopharma Inc. and Martin Babler, dated as of April 23, 2011 (Filed With SEC on September 4, 2018)
- Offer of Employment, by and between Principia Biopharma Inc. and Christopher Chai, dated as of November 26, 2013 (Filed With SEC on September 4, 2018)
- Offer of Employment, by and between Principia Biopharma Inc. and Stefani Wolff, dated as of December 19, 2016 (Filed With SEC on September 4, 2018)
- Offer of Employment, by and between Principia Biopharma Inc. and Steve Gourlay, dated as of July 16, 2018 (Filed With SEC on September 4, 2018)
- Offer of Employment, by and between Principia Biopharma Inc. and David Goldstein, Ph.D., dated as of February 28, 2011 (Filed With SEC on September 4, 2018)
- Offer of Employment, by and between Principia Biopharma Inc. and Roy Hardiman, dated as of December 17, 2014 (Filed With SEC on September 4, 2018)
- Form of Common Stock certificate (Filed With SEC on August 17, 2018)
- Form of Warrant to Purchase Stock (Filed With SEC on August 17, 2018)
- Warrant to Purchase Stock, by and between the Company and Silicon Valley Bank, dated as of September 19, 2011 (Filed With SEC on August 17, 2018)
- Amended and Restated Investors Rights Agreement, dated August 16, 2018 (Filed With SEC on August 17, 2018)
- Principia Biopharma Inc. Amended and Restated 2008 Equity Incentive Plan (Filed With SEC on August 17, 2018)
- Forms of grant notice, stock option agreement and notice of exercise under the Principia Biopharma Inc. 2008 Equity Incentive Plan (Filed With SEC on August 17, 2018)
- Development and License Agreement, by and between the Company and AbbVie Technology Limited, dated as of June 9, 2017 (Filed With SEC on August 17, 2018)
- License Agreement, by and between the Company and Genzyme Corporation, dated as of November 8, 2017 as amended by that certain First Amendment to License Agreement, dated as of... (Filed With SEC on August 17, 2018)
- Amended and Restated Exclusive License Agreement, by and between the Company and The Regents of the University of California, dated as of May 31, 2012 (Filed With SEC on August 17, 2018)
- Amended and Restated Exclusive License Agreement, by and between the Company and The Regents of the University of California, dated as of December 5, 2013 (Filed With SEC on August 17, 2018)
- Lease Agreement, by and between the Company and Are-East Jamie Court, LLC, dated as of May 1, 2011, as amended by that certain First Amendment to Lease, dated as of December 1,... (Filed With SEC on August 17, 2018)
- Lease Agreement, by and between Are-East Jamie Court LLC and Sequenta, Inc., dated as of February 11, 2011, as amended by that certain First Amendment to Lease Agreement, dated... (Filed With SEC on August 17, 2018)
- Lease, by and between Britannia Pointe Grand Limited Partnership and the Company, dated as of April 23, 2018 (Filed With SEC on August 17, 2018)